Efficacy and safety of Iranian made Deferasirox (Osveral®) in Iranian major thalassemic patients with transfusional iron overload: A one year prospective multicentric open-label non-comparative study. (Q35596533)
Jump to navigation
Jump to search
scientific article published on January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of Iranian made Deferasirox (Osveral®) in Iranian major thalassemic patients with transfusional iron overload: A one year prospective multicentric open-label non-comparative study. |
scientific article published on January 2011 |
Statements
Efficacy and safety of Iranian made Deferasirox (Osveral®) in Iranian major thalassemic patients with transfusional iron overload: A one year prospective multicentric open-label non-comparative study (English)
P Eshghi
Z Farahmandinia
M Molavi
M Naderi
M Jafroodi
H Hoorfar
K Davari
A Azarkeivan
B Keikhaie
S Ansari
1 reference